Search filters

List of works by Enrica Marchi

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

scientific article

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial

scientific article published on 21 December 2017

Cancer Testis Antigen Expression Across T-Cell Lymphoma Subtypes

scientific article published on 03 August 2020

Combined Oral 5-Azacytidine and Romidepsin are Highly Effective in Patients with PTCL: A Multicenter Phase 2 Study

scientific article published on 10 November 2020

Development and characterization of a novel CD19CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomas

scientific article

Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas

scientific article published in December 2005

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

scientific article

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

scientific article

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients

scientific article

Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers

scientific article published on 02 July 2020

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL ⬇️

scientific article published on July 19, 2011

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

scientific article published in February 2004

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma

scientific article published in June 2007

Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays

scientific article published on 01 March 2005

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

scientific article published in March 2004

Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series

scientific article published on 26 September 2020

New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination

scientific article published on 27 February 2019

Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

scientific article

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

scientific article published on 01 October 2019

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma

scientific article

Pralatrexate Pharmacology and Clinical Development ⬇️

scientific article published on August 21, 2013

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies

scientific article

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma

scientific article published in January 2007

Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center pha

scientific article published on 28 July 2020

Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action

scientific article published on October 2013

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

scientific article published on 9 March 2009

Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma

scientific article

Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma ⬇️

scientific article published on August 1, 2012

Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma ⬇️

scientific article published on August 2, 2013

Strategy for Assessing New Drug Value in Orphan Diseases: An International Case Match Control Analysis of the PROPEL Study

scientific article published on 01 October 2018

Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials

scientific article published on 29 December 2019

The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor.

scientific article published on 8 July 2009

The anti-tumor activity of pralatrexate (PDX) correlates with the expression of RFC and DHFR mRNA in preclinical models of multiple myeloma

scientific article published on 05 May 2020

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma

scientific article published on 20 July 2015

The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma

scientific article published on 10 April 2015

The peripheral T-cell lymphomas: an unusual path to cure

scientific article published on 01 October 2020

The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management

scientific article published on 09 December 2019

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

scientific article published in November 2007

Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma

scientific article

Paulina is supported by:

About Paulina

Help